Enhancing effect of staurosporine on NO production in rat peritoneal macrophages via a protein kinase C-independent mechanism

Br J Pharmacol. 1995 Sep;116(2):1711-2. doi: 10.1111/j.1476-5381.1995.tb16649.x.

Abstract

Staurosporine (3-100 nM), frequently used as a protein kinase C (PKC) inhibitor, increased accumulation of nitrite in the culture medium of rat peritoneal macrophages up to 6 times above the control level. Moreover, when used in combination with the stable analogue of cyclic AMP, dibutyrylcyclic AMP (db cyclic AMP; 0.1 mM), and/or a cytokine, tumour necrosis factor-alpha (TNF alpha; 100 u ml-1), staurosporine synergistically potentiated, up to 30 times, nitrite accumulation. On the other hand, the other PKC inhibitors, calphostin C and H-7 (10 nM-10 microM) were not effective under the same conditions. The staurosporine-induced nitrite accumulation, in both the presence and the absence of TNF alpha and/or db cyclic AMP was effectively inhibited by the protein synthesis inhibitor, cycloheximide, or by the nitric oxide (NO) synthesis inhibitor, NG-monomethyl-L-arginine (L-NMMA). Thus our data suggest that staurosporine may enhance NO production in macrophages via intracellular mechanisms unrelated to the PKC inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology*
  • Animals
  • Cells, Cultured / drug effects
  • Cyclic AMP / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology*
  • Macrophages, Peritoneal / drug effects*
  • Nitric Oxide / metabolism*
  • Protein Kinase C / drug effects*
  • Rats
  • Staurosporine
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Alkaloids
  • Enzyme Inhibitors
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Cyclic AMP
  • Protein Kinase C
  • Staurosporine